Iodoethane → HCID 22923495, 화합물

HRID 1451920노트

반응식

HRID 1451920 반응식
[CH2:1]([O:3][C:4]([N:6]1[CH2:11][CH2:10][CH:9]([N:12]2[C:21](=[O:22])[C:20]3[C:15](=[CH:16][CH:17]=[C:18]([CH3:23])[CH:19]=3)[NH:14][C:13]2=[O:24])[CH2:8][CH2:7]1)=[O:5])[CH3:2].[CH2:25](I)[CH3:26]>>[CH2:1]([O:3][C:4]([N:6]1[CH2:11][CH2:10][CH:9]([N:12]2[C:21](=[O:22])[C:20]3[C:15](=[CH:16][CH:17]=[C:18]([CH3:23])[CH:19]=3)[N:14]([CH2:25][CH3:26])[C:13]2=[O:24])[CH2:8][CH2:7]1)=[O:5])[CH3:2]

참가 물질

3

반응물 2

HCID 6340IodoethaneHCID 218512463-(1-Ethoxycarbonyl-4-piperidinyl)-1,2,3,4-tetrahydro-6-methyl-2,4-dioxoquinazoline2회

생성물 1

HCID 22923495HCID 22923495, 화합물수율 79%

실험 절차

The procedure similar to that described in Example 1 was repeated, except that 1.0 g (3.02 mmol) of 3-(1-ethoxycarbonyl-4-piperidinyl)-1,2,3,4-tetrahydro-6-methyl-2,4-dioxoquinazoline (Compound f) was used in place of Compound 24 and ethyl iodide was used in place of methyl iodide, whereby 855.0 mg (yield: 79%) of Compound b was obtained as white crystals.

출처 및 근거

ORD 기록
ord-0b00be66f45444a88bbfad858a75bd44
출처 데이터셋
uspto-grants-1997_02
특허 번호
US05605900

반응 노트

불러오는 중…